Public repo g burden for this colection of iformation is eslimae to averae I1thour per repose, inckal" tMe time for reve&in instctions sear&` exmsn data souces, gathser g rn smintar the data needed, end oo"te aid revwi this collection of infonmatbon. Accruing evidence suggests that integrin-dependent cell attachment signaling, and estrogen hormonal response are closely interconnected. For example, studies by us and others of the BCAR proteins (BCARI and BCAR3: (1, 2)) have indicated that these proteins physically associate with each other, and function both in signal transduction relevant to integrin stimulation, and in mediation of Tamoxifen (Tam) resistance. The goal of this proposal was to explore the interrelationship between integrin signaling, cell attachment status, and Tam resistance. A specific hypothesis was that activation of integrin signaling reduces the Tam-dependent inhibition of essential estrogen-dependent transcription. In particular, the proposal sought to explore how the formation of organized three-dimensional structures (spheroids) by metastasizing tumor cells, which greatly enhances their resistance to treatment with a number of drugs (reviewed in (4), might modulate Tam resistance and the estrogen-dependent transcriptional program. As described below, we found that spheroids unexpectedly did not result in increased Tam resistance. However, we did find that manipulation of expression of BCAR1 resulted in changes in the transcription of estrogen-regulated genes, suggesting the initial hypothesis of an integrin-estrogen connection at the level of transcription is worth further investigation.
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Accruing evidence suggests that integrin-dependent cell attachment signaling, and estrogen hormonal response are closely interconnected. For example, studies by us and others of the BCAR proteins (BCARI and BCAR3: (1, 2)) have indicated that these proteins physically associate with each other, and function both in signal transduction relevant to integrin stimulation, and in mediation of Tamoxifen (Tam) resistance. The goal of this proposal was to explore the interrelationship between integrin signaling, cell attachment status, and Tam resistance. A specific hypothesis was that activation of integrin signaling reduces the Tam-dependent inhibition of essential estrogen-dependent transcription. In particular, the proposal sought to explore how the formation of organized three-dimensional structures (spheroids) by metastasizing tumor cells, which greatly enhances their resistance to treatment with a number of drugs (reviewed in (4), might modulate Tam resistance and the estrogen-dependent transcriptional program. As described below, we found that spheroids unexpectedly did not result in increased Tam resistance. However, we did find that manipulation of expression of BCAR1 resulted in changes in the transcription of estrogen-regulated genes, suggesting the initial hypothesis of an integrin-estrogen connection at the level of transcription is worth further investigation.
Golemis, Erica A. INTRODUCTION. This project was intended to study the interrelation between estrogen response and cell microenvironment. In excess of 65% of breast tumors express the estrogen receptor (ER)-alpha protein, which is activated by binding estrogens, moves to the cell nucleus, and turns on the transcription of genes whose function contributes to tumor progression. Tamoxifen (Tam) antagonizes the ability of estrogens to bind ERalpha, resulting in the inhibition of estrogen-dependent genes. Tam therapy is a standard treatment for ER-alpha-positive breast cancers. However, up to 50% of ER-alpha positive tumors do not respond well to Tam. We wished to gain insight into the process of Tam resistance in these tumors.
The specific hypothesis we chose to address was based on the fact that accruing evidence suggested that integrin-dependent cell attachment signaling, and estrogen hormonal response are closely interconnected. For example, studies by us and others of the BCAR proteins (BCARl and BCAR3: (3, 7)) have indicated that these proteins physically associate with each other, and function both in signal transduction relevant to integrin stimulation, and in mediation of Tam resistance. The means by which integrin signaling is protective for Tam treatment has not been established. However, an attractive hypothesis stems from the long established observation that transcriptional programs can be greatly affected by the status of cell shape and cell-cell attachments (e.g. (6)). For instance, formation of organized three-dimensional structures (termed spheroids or globular microlumens) by metastasizing tumor cells greatly enhances their resistance to drug treatment (reviewed in (10)). Hence, formation of organized three-dimensional structures would be predicted to limit the ability of Tam to induce down-regulation of estrogen-dependent transcription.
The objective of the proposal was to test the idea that the formation of integrindependent, three-dimensional spheroids reduces the Tam-dependent regulation of estrogen-dependent transcription. This work was broken down into several different tasks. These were, Task 1. To develop a baseline of growth parameters for two estrogenreceptor positive cell lines, MCF-7 and ZR-75 cells. This would involve plating the cell lines under different growth conditions that would differentially affect integrin signaling, and optimizing timing of plating and drug concentration so as to achieve a good Tam effect (cytostasis, cell death) in cells grown on plastic (i.e., without extensive integrin engagement, or 3D organization. This would allow us to determine an optimal time for mRNA harvest, to perform the subsequent task (Task 2), which was to measure change in ER-alpha dependent transcription in response to cell culture (i.e., integrin ligation) conditions (Months 3-8), using microarrays and bioinformatics to interpretation results. Finally, a complementary Task 3 was to explore the mechanism of integrin-dependent inhibition of Tam-dependent transcriptional effects. This would be done by using various approaches to block integrin signaling, and determining if this restored a transcriptional pattern to resemble.
BODY. This is a revised final report. We apologize for the abbreviated nature of the last report: because of miscommunication with our grants office, we supplied a final report in a format for an NIH RO1 short summary. In this much expanded revision, we not only provide a much more detailed discussion of the project, but also explicitly respond to the comments made by the reviewer of the initial, short, final report. Task 1. Matrices. The first step was to establish differing conditions of cellular microenvironment that might affect integrin signaling. In this effort, there were two scientific issues. The first one was the physical constraints provided by a fibrillar matrix. The second was the provision by the microenvironment of specific ligands that would differentially activate individual integrins: for instance, laminin activates integin alpha3betal, while collagen preferentially activates alpha2betal.
Key studies demonstrating the protective effect of growth in three dimensional microenvironment frequently used Matrigel, which is a complex mixture of multiple components, including laminin, collagen IV, heparan sulfate proteoglycans, and other factors (11) . We wished to thoroughly address the importance of each factor. Hence, for growth conditions, we considered growth on tissue culture plastic; matrigel; collagen; collagen plus laminin; and collagen spiked with Matrigel. For experiments with Matrigel, we also compared protocols in which cells were seeded into a molten Matrigel, as opposed to spread on top of Matrigel (looking ahead to the desire to extract mRNA, we thought this would be facilitated if cells were closer to the surface of the matrix support, and some protocols suggested seeding cells on top of matrix resulted in sufficient infiltration of cells into matrix to obtain biological effect (5), while making them easier to extract.
Cell lines. The second step was the optimization of timing of growth of cell lines in the media. In the papers providing the basis for this study, characteristic differences in growth response to culture on plastic versus Matrigel were observed between cancer cell lines, and cells that maintained epithelial cell characteristics (discussed in (10)). For the latter cells, the ability to form polarized structures played an important role in resistance to apoptosis. For full comparison of effects between transformed and minimally transformed cells, besides using the MCF-7 and ZR-75 cell lines originally proposed in the Concept award, we also used MCF-1 OF and MCF-OA cells. Although these cells are ER-alpha negative, at minimum MCF-1 OF are nevertheless estrogen-and tamoxifenresponsive, probably at least in part due to action on ER-beta (for instance, see (12, 14) ). MCF-1OA cell lines are the major model line used for study of breast cell polarization in 3D culture systems. Beyond these, there are very few relatively normal cell lines to choose from. In plating the cells, we separately evaluated plating of cells into medium already containing Tam, versus allowing cells to first acquire a spheroidal 3D structure (testing time periods ranging from 5 days to 12 days, as discussed in (4, 10, 17) ).
Tamoxifen. For these studies we used standard conditions for cell culture, using DMEM medium (MCF7 and ZR-75) or high calcium medium (MCFOF) with charcoal stripped serum, supplemented with 10 nM estrogen, and concentrations of Tam ranging from 0 to 25 [iM for initial evaluation. We found that a concentration of 20 JAM induced inhibition of proliferation (as measured by Alamar Blue staining) within 2-3 days after addition. We also performed some studies comparing Tam with 4-hydroxytamoxifen (OHT), and found no significant difference for the parameters we assayed.
Results. We assessed the three cell lines to establish growth profile in the different matrices. In cells that had not been challenged with Tam, over the course of 2 weeks, cells grown in matrices gradually grew in microcolonies. Our data were consistent with the published literature. Initially, all cells grew in non-distinguishable clusters, with MCF7, ZR-75, MCF-1OA and MCF1OF cells comparable for the first several days in matrix (Figure 1 were used for each combination of after 10 days of culture in matrix, matrix and Tam. All experiments were repeated at least 3 times. As shown in Figure 3 , the results of these experiments initially surprised us. With Alamar blue staining, bright red color is reflective of viable cell numbers, with growth inhibition reflected by a transition through purple to blue (cytostasis, death). Based on these results, the cells grown on Matrigel and collagen appeared to be more sensitive to Tam than did cells grown on plastic. Comparable results were obtained in the three different cell lines we examined. This was extremely puzzling, because our anticipation based on the literature was that growth in Matrigel or other support matrices would either have a protective effect, or no effect; we did not MCF-10F cells anticipate a sensitization to Tam. Cells were comparably affected by Tam under all matrix growth conditions ( Figure 5 ). We also note that MCF-1OF cells lines behaved similarly to MCF7 and ZR-75 in their response to Tam (Figure 6 ), indicating the presence of ER-alpha was not essential for this proliferations response (again, paralleling published literature, (12)).
We continued exploring different growth conditions to understand this finding. The result of extensive probing of conditions is summarized in the following Figure 7 . In comparison of the proliferation rate of cells, it is clear that several days after initial seeding, the growth rate of cells on matrices slows in comparison to cells grown on plastic. Although this is masked with cells on plastic are approaching a saturating range. reviewer of the first abbreviated final report suggested we examine cytotoxic agents. This experiment was not proposed in the original proposal, and given the negative results of the "./ primary experiment, under conditions in which cells were growing according to described parameters (Figures 1-3 ), this with each cycle of experimentation taking over two weeks, it took considerably longer than anticipated to work through these optimization steps, limiting the time left within the one year concept award. We therefore chose to focus our efforts on the experiments outlined in Task 3, Task 3. In this task, we proposed to directly manipulate integrin signaling, and examine consequences
HEF1
for expression of canonical estrogen-regulated genes. Because of the surprising results of Task 1, we wished to be sure that we were efficiently detecting estrogenplaOCas regulated genes. BCAR1 and the interacting protein BCAR3 were directly connected both to integrin signaling and to regulation of Tam response (1, 7, 15, 16) . BCAR3 (also termed AND-34) physically interacts not only with BCAR1 (also termed pl30Cas), but with HEFR (3, 9). studied by our group (13). pl30Cas is ubiquitously Western analysis. Beta-actin is expressed: HEF1 is primarily restricted to lymphoid and a loading control. epithelial cells, with the latter relevant to breast cancer. To provide the best chance of detecting a measurable estrogen-relevant transcriptional response following manipulation of integrin signaling, we have looked at cells with up-and down-regulated pl30Cas and HEFI. To do so, we evaluated panels of siRNAs to deplete pl30Cas and/or HEFR, picking those that were most effective (Figure 8 ). We also used overexpression cell lines based on MCF7 parental cells, in which a tetracycline-regulated promoter would control induction of HEFR or pl30Cas (e.g., Figure 9 ). For each experiment, we routinely used Western analysis to confirm effective depletion or induction of p130Cas and/or HEFR. We note, although we had only proposed in the original Concept award to use approaches to inhibit integrin signaling, we agree with the reviewer of the first final tTu-HEFI report that it made sense to look both for up and down regulation transcripts known to be estrogen regulated. In addition, we assessed a number of transcripts linked to the process of epithelial-mesenchymal transition, important for breast cancer progression; and some transcripts we thought were "irrelevant" to estrogen signaling, to act as standards for variation seen. transcripts. It is our intent to move these studies to microarray work over the next few months, using a 48 hour timepoint after BCAR1 or HEF I manipulation. ranscript levels (-1), and no significant or consistent change in ranscript levels versus "basal, which is the transcript level in cells expressing empty vector, assigned an arbitrary value of 1.
An important question is whether the effects seen are direct or indirect. Intriguingly, in the past year, one paper has appeared indicating that pl30Cas/BCARI directly associates with ER-alpha (2) to modulate non-genomic effects of estrogen. This would argue in favor of an indirect mechanism, as would the cytoplasmic localization of both BCAR1 and BCAR3: however, the question needs further investigation. There may also be a role for more direct control of estrogen transcription. One recent publication has described a connection between estrogen-signaling and cell-adhesion signaling in metastatic breast cancer based on the function of the Snail repressor protein (8) . In this study, it is shown that absence of estrogen signaling causes upregulation of Snail, a promoter of epithelial-to-mesenchymal transition and metastasis. In ongoing work in our laboratory and with collaborators, we have found that HEFR controls the nuclear accumulation (activity) of Snail ( Figure 10 ). Snail represses the transcription of E-cadherin. We have found that manipulation of HEFI ( Figure 11 ) and pl30Cas (not shown) in each case regulates the accumulation of E-cadherin, an important marker of tumor aggressiveness, and one also known to be affected by estrogen regulation. Our laboratory is continuing to investigate this signaling axis.
KEY RESEARCH ACCOMPLISHMENTS.
" CONCLUSIONS. This study has shown that growth in three dimensions does not influence the ability of Tam to inhibit cell growth. This study has supported the idea that the BCAR proteins, important effectors of integrin signaling that also confer tamoxifen resistance, can regulate at least some estrogen-dependent transcription. However, the pl30Cas and HEFI effects at the level of transcription are not enormous, suggesting that other non-genomic effects leading to resistance to tamoxifen perhaps by increasing overall resistance to apoptosis may be involved. Nevertheless, the ability of these proteins to regulate Snail and E-cadherin indicates that they may at least indirectly communicate with transcriptional machinery known to be important for breast cancer development.
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